AI-Generated Summary

The World Orphan Drug Congress Europe is set to host over 2,000 global experts in Amsterdam for the first time in 2025, addressing the latest advancements and challenges in rare disease research and orphan drug development. The comprehensive agenda spans early R&D, regulatory pathways, clinical trial design, market access, and patient engagement, with a new emphasis on innovative methodological approaches. This premier event serves as a critical platform for networking, learning cutting-edge science, and fostering partnerships within the rare disease community.

In a nutshell

This congress offers a vital forum for pharmaceutical and biotech professionals, researchers, and policymakers to engage with the latest advancements and challenges in orphan drug development. Its broad scope, from early research to policy and commercialization, provides actionable intelligence for stakeholders navigating the complex rare disease landscape.

Source: News-Medical.net